Senate backs bipartisan bill to speed drugs and avert shortages
The Senate passed a major bipartisan bill on Thursday to prevent drug shortages and to speed federal approval of lifesaving medicines, including lower-cost generic versions of biotechnology products. A similar bill is on a fast track to approval in the House. President Obama, consumer groups and pharmaceutical companies strongly support the legislation. The measures reflect the government's effort to keep up with new therapies developed during a decade of rapid progress in biomedical research.
- 'Mega Boards' Could be Rural Healthcare Disruptor
- 1 in 5 Eligible Hospitals Penalized for HACs
- HL20: Rebecca Katz—Cooking Up Sustainable Nourishment
- Meaningful Use Payment Adjustments Begin
- 2015 M&A Forecast 'Cloudy'
- HL20: Peter Semczuk, DDS, MPH—Taking on the Big Challenges
- PA hospital to pay $662,000 to settle Medicare fraud case
- Calculating the True Cost of Care
- HL20: Lee Aase—Who's Behind @MayoClinic
- Supreme Court to hear Obamacare subsidy challenge in March